Onyx Biotec IPO listing price is ₹ 56.75, issue price is ₹ 61.00, and currently trading at ₹ 51.90 as on June 12, 2025. Onyx Biotec IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Onyx Biotec IPO is a Book Building listing on NSE EMERGE exchange. The company is based in Solan and caters to Pharmaceutical sector. Horizon Management is the merchant banker of Onyx Biotec IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 5th August 2024.
Onyx Biotec IPO offer price is ₹ 61.00 and got listed at ₹ 56.75. Read Onyx Biotec IPO details mentioned above.The IPO of Onyx Biotec Limited was listed on 22nd November 2024. As of today, Onyx Biotec IPO is trading at ₹ 51.90, compared to the previous day’s close of ₹ 50.00. Read the report above for detailed IPO performance.
The issue price of Onyx Biotec IPO was ₹ 61.00 per equity share.
Onyx Biotec IPO was listed at ₹56.75 on the stock exchange on 22nd November 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 12, 2025, the current market price of Onyx Biotec IPO is ₹ 51.90.
The 52-week high for Onyx Biotec IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Onyx Biotec IPO listed at ₹ 56.75 against the issue price of ₹ 61.00 per equity share, showing a listing day gain/loss of -4.25 (-6.97%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Onyx Biotec IPO stock moved from its listing price of ₹ 56.75 to the current price of ₹51.90 per equity share, reflecting a change of -8.55% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Onyx Biotec IPO issue date of 22nd November 2024 and CMP of ₹51.90, the estimated CAGR is approximately -25%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Onyx Biotec IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Onyx Biotec Financial Review Page
Merchant Banker(s) of Onyx Biotec IPO: Horizon Management Private Limited
Onyx Biotec IPO subscription was 198.00 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Onyx Biotec IPO listed at a listing price of 56.75 against the offer price of 61.00.
The current market price of Onyx Biotec is 51.90.
Why Us?